CHELMSFORD, Mass., December 02, 2025--(BUSINESS WIRE)--ZOLL ®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the complete U.S. rollout of its next ...

CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that physicians at all of the 14 ...

LifeVest Wearable Defibrillator Prescribed by Physicians at All U.S. News and World Report’s #1 Ranked “Top Metro” Hospitals The LifeVest is worn by patients at risk for SCA, providing protection ...

CHELMSFORD, Mass., December 19, 2025--(BUSINESS WIRE)--ZOLL ®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation ...

Medical devices and related software solutions maker ZOLL has introduced its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the US. The latest device is the fifth LifeVest WCD, ...

A phase 3 trial of Zoll Medical’s LifeVest has missed its primary endpoint. The study found that people who started using the wearable defibrillator the week after they had a heart attack were as ...

Zoll Medical Corporation, which received FDA clearance a few years ago for both home and hospital versions of its wearable defibrillator LifeVest, is now dealing with a range of lawsuits and FDA ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the complete U.S. rollout of its next generation garment for the LifeVest® wearable ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).

Backed by decades of continuous innovation informed by patient feedback, LifeVest continues to set the standard in the WCD market. LifeVest delivers highly effective, safe therapy for patients at risk ...